Robert Redfield
Chief Medical Officer · Traws Pharma, Inc.
Individual
- 2025
- Jul 15, 2026
- 4
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Robert Redfield files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ORBIMED ADVISORS LLC - $998K in TRAW purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Robert Redfield?
Robert Redfield is a corporate insider, tracked as Chief Medical Officer of Traws Pharma, Inc. (TRAW). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Robert Redfield last file a Form 4?
The most recent primary Form 4 on record is dated 15 July 2026, one of 4 filings going back to 2025.
